Sunday, September 22, 2024
HomeVehiclesCNHTC (+40.9%), JAC (+32%) impress, gross sales edge up 1% – Greatest...

CNHTC (+40.9%), JAC (+32%) impress, gross sales edge up 1% – Greatest Promoting Vehicles Weblog


JAC LCV sales are up 32% year-on-year in April.

Sales of Light Commercial Vehicles in China edge up 1% year-on-year in March to 322,539 units, a paltry result considering March 2022 was off -24% on the year prior. The year-to-date tally is down -7% to 718,491. Foton (+12.5%) posts a solid gain to retain the lead of the brands ranking above Wuling (-27.5%) hit full frontal again. Changan (+2.1%) edges up above Dongfeng (-2.3%). CNHTC (+40.9%) and JAC (+32%) deliver the largest year-on-year upticks in the Top 10, with Great Wall (+8.3%) also very dynamic. Model-wise, the Foton Light Truck (+11.3%) stays on top while the Wuling Mini Truck (-25.4%) returns to #2 and the Changan Light Truck (+11.8%) rounds out the podium.

Previous month: China LCV February 2023: Foton Light Truck, Great Wall Pao shine in market up 37%

One year ago: China LCV March 2022: Market down -24%, Wuling reclaims lead

Full March 2023 Top 10 brands and Top 3 models below.

China LCV March 2023 – brands:

Pos Brand Mar-23 /22 Feb 2023 /22 Pos FY22
1 Foton 52,393 12.5% 1 121,430 15.8% 1 2
2 Wuling 48,610 -27.5% 2 93,998 -26.0% 2 1
3 Changan 37,295 2.1% 3 84,689 -26.1% 3 3
4 Dongfeng 25,318 -2.3% 4 55,915 -19.0% 4 4
5 JAC 20,988 32.0% 5 50,231 -7.6% 5 7
6 Great Wall 19,981 8.3% 6 48,817 13.7% 6 5
7 Maxus 15,220 1.6% 7 40,839 0.9% 7 6
8 JMC 13,678 -29.1% 9 29,235 -29.8% 9 8
9 Jinbei 13,600 5.2% 8 29,995 -5.5% 8 9
10 CNHTC 11,118 40.9% 10 23,598 4.7% 10 n/a

China LCV March 2023 – models:

Pos Model Mar-23 /22 Feb 2023 /22 Pos FY22
1 Foton Light Truck 43,989 11.3% 1 101,856 12.8% 1 1
2 Wuling Mini Truck 26,044 -25.4% n/a 38,412 -45.4% 3 2
3 Changan Light Truck 17,633 11.8% 2 40,853 -17.4% 2 3

Source: LMC Automotive

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments